Growth Metrics

Acadia Pharmaceuticals (ACAD) Net Income towards Common Stockholders (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -98.67%
Dec 31, 2025 281.13%
Sep 30, 2025 169.18%
Jun 30, 2025 40.44%
Mar 31, 2025 -86.79%
Dec 31, 2024 338.71%
Sep 30, 2024 -1.87%
Jun 30, 2024 101.69%
Mar 31, 2024 -63.85%
Dec 31, 2023 170.27%
Sep 30, 2023 -5,950.63%
Jun 30, 2023 102.59%
Mar 31, 2023 -3.23%
Dec 31, 2022 -53.40%
Sep 30, 2022 20.02%
Jun 30, 2022 69.95%
Mar 31, 2022 -162.35%
Dec 31, 2021 -198.08%
Sep 30, 2021 67.05%
Jun 30, 2021 33.98%
Mar 31, 2021 0.15%
Dec 31, 2020 21.39%
Sep 30, 2020 -100.90%
Jun 30, 2020 52.13%
Mar 31, 2020 -65.97%
Dec 31, 2019 -26.34%
Sep 30, 2019 23.59%
Jun 30, 2019 35.59%
Mar 31, 2019 -30.16%
Dec 31, 2018 -5.47%
Sep 30, 2018 1.78%
Jun 30, 2018 -16.52%
Mar 31, 2018 21.14%
Dec 31, 2017 -5.52%
Sep 30, 2017 3.25%
Jun 30, 2017 23.23%
Mar 31, 2017 -13.56%
Dec 31, 2016 -8.02%
Sep 30, 2016 -0.41%
Jun 30, 2016 -43.33%
Mar 31, 2016 -178.54%
Dec 31, 2015 262.85%
Sep 30, 2015 1.20%
Jun 30, 2015 2.47%
Mar 31, 2015 -220.80%
Dec 31, 2014 234.85%
Sep 30, 2014 -15.31%
Jun 30, 2014 -20.57%
Mar 31, 2014 -233.58%
Dec 31, 2013 224.79%
Sep 30, 2013 -17.77%
Jun 30, 2013 -48.31%
Mar 31, 2013 10.09%
Dec 31, 2012 -183.51%
Sep 30, 2012 55.67%
Jun 30, 2012 12.85%
Mar 31, 2012 -17.32%
Dec 31, 2011 -4.41%
Sep 30, 2011 22.57%
Jun 30, 2011 -12.39%
Mar 31, 2011 -120.02%
Dec 31, 2010 789.40%